Elder Pharma Fact Sheet, Elder Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Elder Pharma Fact Sheet    (ELDER)


Revealing Tomorrow: The Great Indian Wealth Project


Here is the latest financial fact sheet of Elder Pharma. For more details, see the Elder Pharma quarterly results and Elder Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

ELDER PHARMA Price History

Price Rs 38.0
Mkt Cap Rs m 781
Vol '000 20.5
P/E X -0.2
P/CF X 2.6
EPS (TTM) Rs -220.6
% ch % 5.0
No. of shares m 20.54
% ch week % 5.0
% ch 1-mth % 27.1
% ch 12-mth % -64.5
52 week H/L Rs 118.8/20.4
(As on Sep 12, 2016 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ELDER PHARMA Financials

No. of Mths
Year Ending
12
Mar-11
*
12
Mar-12
*
12
Mar-13
*
15
Jun-13
*
12
Jun-14
*
5-Yr Chart
Click to enlarge
ELDER PHARMA EQUITY SHARE DATA
High Rs440435416416380 
Low Rs321298202202188 
Sales per share (Unadj.) Rs470.0649.8799.3799.3491.2 
Earnings per share (Unadj.) Rs31.335.240.140.1-3.2 
Diluted earnings per shareRs31.335.240.140.1-3.2 
Cash flow per share (Unadj.) Rs45.351.761.661.614.4 
Dividends per share (Unadj.) Rs3.003.00000 
Adj. dividends per shareRs3.003.000.000.000.00 
Dividend yield (eoy) %0.80.8000 
Book value per share (Unadj.) Rs307.0341.1374.5374.5376.5 
Adj. book value per shareRs307.0341.1374.5374.5376.5 
Shares outstanding (eoy) m20.5420.5420.5420.5420.54 
Bonus / Rights / Conversions  PP---- 
Price / Sales ratio x0.80.60.40.40.6 
Avg P/E ratio x12.210.47.77.7-89.3 
P/CF ratio (eoy) x8.47.15.05.019.7 
Price / Book Value ratio x1.21.10.80.80.8 
Dividend payout %9.68.5000 
Avg Mkt Cap Rs m7,8157,5286,3486,3485,833 
No. of employees `0003.63.5NANANA 
Total wages/salary Rs m1,2261,7992,3312,3312,179 
Avg. sales/employee Rs Th2,674.63,773.8NMNMNM 
Avg. wages/employee Rs Th339.7508.6NMNMNM 
Avg. net profit/employee Rs Th178.0204.3NMNMNM 
ELDER PHARMA INCOME DATA
Net Sales Rs m9,65313,34816,41716,41710,089 
Other income Rs m87265327327257 
Total revenues Rs m9,73913,61316,74416,74410,346 
Gross profit Rs m1,3311,9902,7342,734-792 
Depreciation Rs m287340441441361 
Interest Rs m2811,0161,5481,5482,756 
Profit before tax Rs m8499001,0711,071-3,653 
Minority Interest Rs m70000 
Prior Period Items Rs m80000 
Extraordinary Inc (Exp) Rs m-4515-28-283,713 
Tax Rs m177193219219125 
Profit after tax Rs m642723824824-65 
Gross profit margin %13.814.916.716.7-7.8 
Effective tax rate %20.821.420.520.5-3.4 
Net profit margin %6.75.45.05.0-0.6 
ELDER PHARMA BALANCE SHEET DATA
Current assets Rs m8,2788,7828,7918,7919,240 
Current liabilities Rs m5,8036,9579,9989,9989,998 
Net working cap to sales %25.613.7-7.4-7.4-7.5 
Current ratio x1.41.30.90.90.9 
Inventory Days Days9180545446 
Debtors Days Days10793898960 
Net fixed assets Rs m7,4258,9739,6319,63110,124 
Share capital Rs m206206206206206 
"Free" reserves Rs m5,4365,7906,1216,1215,582 
Net worth Rs m6,3077,0067,6937,6937,734 
Long term debt Rs m5,0955,8257,0397,0394,889 
Total assets Rs m17,41519,99824,92524,92522,882 
Interest coverage x4.01.91.71.7-0.3 
Debt to equity ratio x0.80.80.90.90.6 
Sales to assets ratio x0.60.70.70.70.4 
Return on assets %5.38.79.59.511.8 
Return on equity %10.210.310.710.7-0.8 
Return on capital %9.615.017.617.622.3 
Exports to sales %2.42.11.91.93.0 
Imports to sales %3.62.31.81.80.4 
Exports (fob) Rs m228280318318307 
Imports (cif) Rs m35130629129143 
Fx inflow Rs m228280318318307 
Fx outflow Rs m388334361361125 
Net fx Rs m-160-54-43-43181 
ELDER PHARMA CASH FLOW
From Operations Rs m 657 148 194 166 11,754 
From Investments Rs m -1,507 -1,711 -632 -632 -561 
From Financial Activity Rs m 2,734 433 -67 -39 -6,762 
Net Cashflow Rs m 1,885 -1,131 -506 -506 4,432 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 39.6%
Foreign collaborators 0.0%
Indian inst/Mut Fund 7.5%
FIIs 16.8%
ADR/GDR 0.0%
Free float 36.1%
Shareholders 16,479
Pledged promoter(s) holding 77.6%
 

Company Information

REGD OFF Elder House, Plot No. C-9, Dalia Indl. Estate, Off Veera Desai Road, Mumbai-53
E-MAIL s.p.date@elderindia.com WEB www.elderindia.com
TELEPHONE (022) 2673 0058 FAX (022) 2673 0051
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Intime Spectrum, C-13, Pannalal Silk Mills Compd., LBS Marg, Mumbai - 78
AUDITOR S. S. Khandelwal & Co.
CHM: J. Saxena COMP SEC: S. P. Date YEAR OF INC: 1900 BSE CODE: 532322 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   SHASUN PHARMA  PFIZER  INDRAPRASTHA MEDICAL  TTK HEALTHCARE  PANACEA BIOTECH  

Compare ELDER PHARMA With:   SHASUN PHARMA  PFIZER  INDRAPRASTHA MEDICAL  TTK HEALTHCARE  PANACEA BIOTECH  

Compare ELDER PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  




Today's Market

Sensex, Nifty End Flat; Asian Paints, UPL & ITC Among Top Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Views on news

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ELDER PHARMA

ELDER PHARMA - NATCO PHARMA COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS